ProstaLund AB (publ) (PLUN.ST)
SEK 0.22
(-3.86%)
SEK 0.22
(-3.86%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 10.21 Million SEK | 9.18% |
| 2022 | 9.35 Million SEK | 16.61% |
| 2021 | 8.02 Million SEK | 46.29% |
| 2020 | 5.48 Million SEK | 31.95% |
| 2019 | 4.15 Million SEK | -35.5% |
| 2018 | 6.44 Million SEK | 55.34% |
| 2017 | 4.14 Million SEK | -6.15% |
| 2016 | 4.42 Million SEK | 13.1% |
| 2015 | 3.9 Million SEK | -1.54% |
| 2014 | 3.97 Million SEK | -9.3% |
| 2013 | 4.37 Million SEK | 96.9% |
| 2012 | 2.22 Million SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 12.49 Million SEK | 85.32% |
| 2024 Q1 | 6.74 Million SEK | -34.01% |
| 2023 FY | 10.21 Million SEK | 9.18% |
| 2023 Q4 | 10.21 Million SEK | 1.96% |
| 2023 Q2 | 14.12 Million SEK | 96.37% |
| 2023 Q1 | 7.19 Million SEK | -23.15% |
| 2023 Q3 | 10.02 Million SEK | -29.04% |
| 2022 Q2 | 10.58 Million SEK | 13.8% |
| 2022 Q4 | 9.35 Million SEK | 32.25% |
| 2022 FY | 9.35 Million SEK | 16.61% |
| 2022 Q1 | 9.3 Million SEK | 15.94% |
| 2022 Q3 | 7.07 Million SEK | -33.17% |
| 2021 Q4 | 8.02 Million SEK | 32.08% |
| 2021 FY | 8.02 Million SEK | 46.29% |
| 2021 Q3 | 6.07 Million SEK | 8.23% |
| 2021 Q2 | 5.61 Million SEK | -16.61% |
| 2021 Q1 | 6.73 Million SEK | 22.72% |
| 2020 Q3 | 4.56 Million SEK | 5.75% |
| 2020 Q4 | 5.48 Million SEK | 20.29% |
| 2020 FY | 5.48 Million SEK | 31.95% |
| 2020 Q1 | 6.65 Million SEK | 60.04% |
| 2020 Q2 | 4.31 Million SEK | -35.19% |
| 2019 Q4 | 4.15 Million SEK | -4.02% |
| 2019 Q1 | 6.96 Million SEK | 8.01% |
| 2019 Q3 | 4.33 Million SEK | -49.77% |
| 2019 Q2 | 8.62 Million SEK | 23.88% |
| 2019 FY | 4.15 Million SEK | -35.5% |
| 2018 FY | 6.44 Million SEK | 55.34% |
| 2018 Q1 | 4.4 Million SEK | 6.24% |
| 2018 Q4 | 6.44 Million SEK | 93.54% |
| 2018 Q2 | 3.79 Million SEK | -13.91% |
| 2018 Q3 | 3.33 Million SEK | -12.25% |
| 2017 FY | 4.14 Million SEK | -6.15% |
| 2017 Q3 | 3.64 Million SEK | -23.19% |
| 2017 Q2 | 4.74 Million SEK | 15.4% |
| 2017 Q1 | 4.11 Million SEK | -7.03% |
| 2017 Q4 | 4.14 Million SEK | 13.89% |
| 2016 Q1 | 3.61 Million SEK | -7.57% |
| 2016 FY | 4.42 Million SEK | 13.1% |
| 2016 Q2 | 3.71 Million SEK | 2.85% |
| 2016 Q4 | 4.42 Million SEK | 18.94% |
| 2016 Q3 | 3.71 Million SEK | 0.03% |
| 2015 Q1 | 3 Million SEK | -24.28% |
| 2015 FY | 3.9 Million SEK | -1.54% |
| 2015 Q4 | 3.9 Million SEK | -11.82% |
| 2015 Q3 | 4.43 Million SEK | 8.76% |
| 2015 Q2 | 4.07 Million SEK | 35.6% |
| 2014 Q4 | 3.97 Million SEK | 4.5% |
| 2014 Q1 | 4.38 Million SEK | 0.18% |
| 2014 FY | 3.97 Million SEK | -9.3% |
| 2014 Q3 | 3.79 Million SEK | 12.86% |
| 2014 Q2 | 3.36 Million SEK | -23.24% |
| 2013 Q2 | 3.68 Million SEK | 0.0% |
| 2013 Q1 | - SEK | -100.0% |
| 2013 Q3 | 3.97 Million SEK | 7.86% |
| 2013 FY | 4.37 Million SEK | 96.9% |
| 2013 Q4 | 4.37 Million SEK | 10.03% |
| 2012 FY | 2.22 Million SEK | 0.0% |
| 2012 Q4 | 1.65 Million SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ambea AB (publ) | 12.97 Billion SEK | 99.921% |
| Attendo AB (publ) | 17.53 Billion SEK | 99.942% |
| Humana AB (publ) | 7.1 Billion SEK | 99.856% |